Personal tools

MCL coexpression mm9:2986: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.664214338129335,0.381636141962868,0.231008947931991,0.127893569522672,0.0642873521037868,0,0.0699790221274244,0,0,0,0,0.0558041721483835,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0673620022139481,0.876694568058672,0.428210788219066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198582584603541,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.264512262907024,0.204093579732844,0.140259928189304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231013950740173,0.0994554632344034,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.760376943436681,1.03328707850495,0.621030737309247,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.664214338129335,0.381636141962868,0.231008947931991,0.127893569522672,0.0642873521037868,0,0.0699790221274244,0,0,0,0,0.0558041721483835,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0673620022139481,0.876694568058672,0.428210788219066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198582584603541,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.264512262907024,0.204093579732844,0.140259928189304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231013950740173,0.0994554632344034,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.760376943436681,1.03328707850495,0.621030737309247,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=
|gostat_on_MCL_coexpression=
|ontology_enrichment_celltype=CL:0000791!1.37e-32!9;CL:0000789!1.37e-32!9;CL:0002420!1.37e-32!9;CL:0002419!1.37e-32!9;CL:0000790!1.37e-32!9;CL:0000988!2.13e-30!32;CL:0002032!2.13e-30!32;CL:0000037!2.13e-30!32;CL:0000566!2.13e-30!32;CL:0000837!2.13e-30!32;CL:0000838!2.19e-30!12;CL:0000624!4.47e-28!8;CL:0000542!5.80e-28!13;CL:0000051!5.80e-28!13;CL:0000084!1.65e-26!11;CL:0000827!1.65e-26!11;CL:0002320!1.68e-23!46;CL:0000134!1.68e-23!46;CL:0002242!1.65e-22!16;CL:0000738!4.06e-21!17;CL:0002087!4.06e-21!17;CL:0000219!1.12e-19!54;CL:0000893!5.84e-19!6;CL:0002489!5.84e-19!6;CL:0000898!5.84e-19!6;CL:0000809!5.84e-19!6;CL:0000810!5.84e-19!6;CL:0000895!5.84e-19!6;CL:0000808!5.84e-19!6;CL:0000894!5.84e-19!6;CL:0000806!5.84e-19!6;CL:0000807!5.84e-19!6;CL:0000805!5.84e-19!6;CL:0002425!5.84e-19!6;CL:0002436!5.84e-19!6;CL:0002427!5.84e-19!6;CL:0002428!5.84e-19!6;CL:0002429!5.84e-19!6;CL:0002433!5.84e-19!6;CL:0002431!5.84e-19!6;CL:0002432!5.84e-19!6;CL:0002031!3.71e-17!25;CL:0000034!4.97e-15!97;CL:0000723!1.09e-10!91;CL:0000048!1.09e-10!91;CL:0000049!2.68e-08!19;CL:0000548!6.24e-08!115;CL:0000255!6.24e-08!115;CL:0002371!1.15e-07!118
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002384!1.68e-23!46
}}
}}

Revision as of 19:20, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr15:57996381..57996420,-p@chr15:57996381..57996420
-
Mm9::chr1:132916420..132916429,+p1@Il10
Mm9::chr9:66730263..66730273,-p@chr9:66730263..66730273
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Cell Type
Ontology termp-valuen
mature alpha-beta T cell1.37e-329
alpha-beta T cell1.37e-329
immature T cell1.37e-329
mature T cell1.37e-329
immature alpha-beta T cell1.37e-329
hematopoietic cell2.13e-3032
hematopoietic oligopotent progenitor cell2.13e-3032
hematopoietic stem cell2.13e-3032
angioblastic mesenchymal cell2.13e-3032
hematopoietic multipotent progenitor cell2.13e-3032
lymphoid lineage restricted progenitor cell2.19e-3012
CD4-positive, alpha-beta T cell4.47e-288
lymphocyte5.80e-2813
common lymphoid progenitor5.80e-2813
T cell1.65e-2611
pro-T cell1.65e-2611
connective tissue cell1.68e-2346
mesenchymal cell1.68e-2346
nucleate cell1.65e-2216
leukocyte4.06e-2117
nongranular leukocyte4.06e-2117
motile cell1.12e-1954
thymocyte5.84e-196
double negative thymocyte5.84e-196
naive T cell5.84e-196
double-positive, alpha-beta thymocyte5.84e-196
CD4-positive, alpha-beta thymocyte5.84e-196
naive thymus-derived CD4-positive, alpha-beta T cell5.84e-196
DN4 thymocyte5.84e-196
DN1 thymic pro-T cell5.84e-196
DN2 thymocyte5.84e-196
DN3 thymocyte5.84e-196
immature single positive thymocyte5.84e-196
early T lineage precursor5.84e-196
mature CD4 single-positive thymocyte5.84e-196
resting double-positive thymocyte5.84e-196
double-positive blast5.84e-196
CD69-positive double-positive thymocyte5.84e-196
CD69-positive, CD4-positive single-positive thymocyte5.84e-196
CD4-positive, CD8-intermediate double-positive thymocyte5.84e-196
CD24-positive, CD4 single-positive thymocyte5.84e-196
hematopoietic lineage restricted progenitor cell3.71e-1725
stem cell4.97e-1597
somatic stem cell1.09e-1091
multi fate stem cell1.09e-1091
common myeloid progenitor2.68e-0819
animal cell6.24e-08115
eukaryotic cell6.24e-08115
somatic cell1.15e-07118

Uber Anatomy
Ontology termp-valuen
connective tissue1.68e-2346


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:2986&oldid=2155272"